Jacob A. Udell MD, MPH, FRCPCAssistant Professor of Medicine, Division of Cardiology, Department of Medicine, Peter Munk Cardiac Centre, Toronto General Hospital and Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada
Jacob A. Udell is a Cardiologist and Clinician-Scientist at Women’s College Hospital and the Peter Munk Cardiac Centre, Toronto General Hospital at the University of Toronto, with emerging expertise in observational studies, clinical trials, and health services research. His team’s work on innovative cardiovascular risk factor identification and therapy has led to alterations in international cardiovascular and diabetes clinical practice guidelines; and changes by the FDA in the label of glycemic therapies. Utilizing the administrative health care databases, registries, and clinical trial populations at his disposal, Dr. Udell studies the cardiovascular benefits and risks of diabetes and antiplatelet therapies and other novel therapies, including influenza vaccination. He is a co-principal investigator of the NHLBI-sponsored INVESTED randomized controlled trial, which is investigating the cardiovascular benefit of high-dose versus standard-dose influenza vaccination.
Disclosures: Dr. Udell reports honoraria for advisory relationships from Amgen, Boehringer-Ingelheim, Janssen, Novartis, and Sanofi Pasteur; and grants from AstraZeneca and Novartis.